52 Chapter 2 33. Caine C, Deshmukh S, Gondi V, et al. CogState computerized memory tests in patients with brain metastases: Secondary endpoint results of NRG oncology RTOG 0933. J Neurooncol 2016; 126: 327–336. 34. Cheng H, Chen H, Lv Y, et al. Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer. Cancer Med. Epub ahead of print 2018. DOI: 10.1002/cam4.1784. 35. Deng X, Zheng Z, Lin B, et al. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases. BMC Cancer 2017; 17: 42. 36. Li J, Bentzen SM, Li J, et al. Relationship Between Neurocognitive Function and Quality of Life After Whole-Brain Radiotherapy in Patients With Brain Metastasis. Int J Radiat Oncol Biol Phys 2008; 71: 64–70. 37. Li J, Bentzen SM, Renschler M, et al. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. Journal of Clinical Oncology 2007; 25: 1260–1266. 38. Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. Journal of Clinical Oncology 2004; 22: 157–165. 39. Zhan Y, Jiang X. Concomitant treatment of brain metastases with whole brain radiotherapy and temozolomide protects neurocognitive function and improve quality of life. Tropical Journal of Pharmaceutical Research 2018; 17: 1209–1213. 40. Zhu Y, Fu L, Jing W, et al. Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastases. Thorac Cancer 2018; 9: 1121–1128. 41. Westover KD, Mendel JT, Dan T, et al. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer. Neuro Oncol 2020; 22: 1831–1839. 42. Westover KD, Mendel JT, Dan T, et al. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer. Neuro Oncol 2020; 22: 1831–1839. 43. van der Meer PB, Habets EJJ, Wiggenraad RG, et al. Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy. J Neurooncol 2018; 139: 359–368. 44. Minniti G, Capone L, Nardiello B, et al. Neurological outcome and memory performance in patients with 10 or more brain metastases treated with frameless linear accelerator (LINAC)-based stereotactic radiosurgery. J Neurooncol 2020; 148: 47–55. 45. van der Meer PB, Habets EJJ, Wiggenraad RG, et al. Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy. J Neurooncol 2018; 139: 359–368. 46. Cheng H, Chen H, Lv Y, et al. Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer. Cancer Med 2018; 7: 5315–5321. 47. Welzel G, Fleckenstein K, Schaefer J, et al. Memory Function Before and After Whole Brain Radiotherapy in Patients With and Without Brain Metastases. Int J Radiat Oncol Biol Phys 2008; 72: 1311–1318.
RkJQdWJsaXNoZXIy MTk4NDMw